title: Mid-trimester termination for fetal abnormality: advantages of a new regimen using mifepristone and misoprostol.
authors.affiliation: University Department of Obstetrics and Gynaecology, Aberdeen Maternity Hospital, UK.
authors.forename: K
authors.initials: K
authors.lastname: Hinshaw
authors.forename: H
authors.initials: H
authors.lastname: el-Refaey
authors.forename: R
authors.initials: R
authors.lastname: Rispin
authors.forename: A
authors.initials: A
authors.lastname: Templeton
mesh_terms: D000028:Abortion, Induced / Q000379:methods*; D000282:Administration, Intravaginal; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D005260:Female; D005333:Fetus / Q000002:abnormalities*; D006801:Humans; D015735:Mifepristone; D016595:Misoprostol; D011247:Pregnancy; D011262:Pregnancy Trimester, Second
chemical_list: D016595:Misoprostol; D015735:Mifepristone